Diagnostic Problems in Anal Pathology
- 1 September 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Advances in Anatomic Pathology
- Vol. 15 (5), 263-278
- https://doi.org/10.1097/pap.0b013e318183234b
Abstract
Anal squamous cell carcinoma and its precursor lesions are increasing in incidence in the United States and Europe. This trend predates human immunodeficiency virus/acquired immune deficiency syndrome and has been associated with persistent high-risk human papilloma virus (HPV) genotype infection, previous lower genital tract dysplasia/carcinoma, high frequency anoreceptive intercourse, heavy cigarette smoking, immunosuppression in solid organ transplant and immune disorders, and human immunodeficiency virus seropositivity. Screening protocols for at-risk patients are under active investigation and pathologists are often asked to assess anal canal and perianal biopsies for the presence of dysplasia and/or invasive carcinoma. Because underdiagnosis and overdiagnosis of anal cancer and precancer may lead to inappropriate treatment, it is important for the pathologist to be aware of current screening strategies, specific risk lesions, and the role of pathology in initial diagnosis and evaluation of anal biopsy and/or resection specimens. Standardized histologic criteria and uniform terminology should be used for reporting all anal canal and perianal squamous intraepithelial lesions. HPV subtyping, anal cytology, and recently identified biomarkers, such as p16INK4a and Becton Dickinson ProEx C may provide additional information in problematic cases, but it is important to be aware of the limitations of these assays. HPV has been linked to all the major histologic subtypes of anal carcinoma (eg, basaloid, cloacogenic, transitional, etc.) and this association is strongest for anal canal lesions. With the possible exception of the microcystic pattern, histologic subtype does not seem to predict prognosis; and anal squamous cell carcinomas should be classified as either keratinizing or nonkeratinizing. Poorly differentiated squamous cell carcinomas have a worse prognosis and should be distinguished from poorly differentiated adenocarcinoma, melanoma, and neuroendocrine tumors. Very well differentiated squamous cell carcinoma with pushing margins (so-called giant condyloma of Buschke and Lowenstein) should be classified as verrucous carcinoma; this tumor shows aggressive local infiltration but does not metastasize. As all anal condylomata may harbor foci of high-grade dysplasia or invasive carcinoma, careful sectioning and complete histologic examination is required.Keywords
This publication has 62 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serologyAPMIS, 2007
- Anal Human Papillomavirus Infection in Women and Its Relationship with Cervical InfectionCancer Epidemiology, Biomarkers & Prevention, 2005
- Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with menAIDS, 2005
- Anal cancer in renal transplant patientsInternational Journal of Colorectal Disease, 2005
- Interobserver agreement in the interpretation of anal intraepithelial neoplasiaCancer, 2005
- The etiology and epidemiology of anal cancerSurgical Oncology Clinics of North America, 2004
- Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women.JNCI Monographs, 1998
- Interobserver variation in the reporting of the histopathological grading of anal intraepithelial neoplasia.Journal of Clinical Pathology, 1994
- Aetiological parallel between anal cancer and cervical cancerThe Lancet, 1991